 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
FDA Approved AIDS DrugOctober 29, 2001 The U.S. Food and Drug Administration (FDA) on Friday approved Viread, a new once-daily pill to treat HIV. San Francisco AIDS specialist Dr. Stephan Becker, who treated more than two dozen patients with Viread in clinical trials prior to federal approval, said the drug reduced HIV levels without the side effects that are common with other drugs. "This is exactly what we had hoped for," said AIDS activist Martin Delaney. "This is going to be an important drug for AIDS treatment at every stage of the disease." The FDA approved Viread for all patients, including those being treated for the first time. Delaney and others had feared the drug would be limited to those patients resistant to other treatments. Gilead will begin shipping Viread to pharmacies this week. A year's supply will cost $4,135. Associated Press 10.28.01  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
